Patents by Inventor Jean-Michel Coindre

Jean-Michel Coindre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9708666
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of soft tissue sarcoma cancer phenotypes and soft tissue sarcoma cancer-associated diseases. Also described herein are methods that can be used to identify modulators of soft tissue sarcoma cancer.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: July 18, 2017
    Assignees: Université Bordeaux Segalen, Institut Bergonié, Institut curie
    Inventors: Frédéric Chibon, Jean-Michel Coindre, Alain Aurias
  • Publication number: 20130288250
    Abstract: A method for in vitro predicting survival and/or metastatic outcome of gastrointestinal stromal tumors (GISTs), characterized in that it comprises the measure of the level, in a patient-derived biological sample of GIST, of a pool of polypeptides or polynucleotides consisting in Aurora kinase A (AURKA); a kit for the in vitro prediction of the survival outcome of a patient suffering from GIST, and/or the development of metastases in a patient treated for or suffering from GIST, and/or the prediction of the efficacy of a treatment for GIST, characterized in that it comprises means for detecting and/or quantify, in a sample, AURKA expression or level, and means for the calculation of the GI; and a method for screening for compounds for the use in the treatment of GISTs and to an AURKA inhibitor for its use in the treatment of GISTs.
    Type: Application
    Filed: October 20, 2011
    Publication date: October 31, 2013
    Applicants: UNIVERSITE BORDEAUX SEGALEN, INSTITUE CURIE, INSTITUT BERGONIE, INSERM
    Inventors: Frédéric Chibon, Jean-Michel Coindre, Alain Aurias
  • Publication number: 20130065772
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of soft tissue sarcoma cancer phenotypes and soft tissue sarcoma cancer-associated diseases. Also described herein are methods that can be used to identify modulators of soft tissue sarcoma cancer.
    Type: Application
    Filed: April 21, 2010
    Publication date: March 14, 2013
    Applicants: Universite Bordeaux Segalen, Institut Curie, Institut Bergonie
    Inventors: Frédéric Chibon, Jean-Michel Coindre, Alain Aurias